Related Experiment Video
Updated: May 11, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Renal function following fistulography in patients with advanced chronic kidney disease
Marlene Hill1, Maria K Mor, Lesli Travis
1Renal Section, Medical Specialty Service Line, VA Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA.
Insights
Fistulography using small amounts of contrast dye in advanced chronic kidney disease (CKD) patients did not accelerate kidney function decline. This procedure is safe for CKD patients needing arteriovenous fistula evaluation.
Area of Science:
- Nephrology
- Radiology
- Vascular Surgery
Background:
- Contrast-induced acute kidney injury (CIAKI) can worsen chronic kidney disease (CKD).
- Fistulography is a common procedure for evaluating arteriovenous fistulae in CKD patients.
- The impact of fistulography on CKD progression is not well-characterized.
Purpose of the Study:
- To assess the rate of kidney function loss after fistulography in advanced CKD patients.
- To determine if fistulography accelerates the progression of underlying chronic kidney disease.
Main Methods:
- Retrospective study of stage 4-5 CKD patients undergoing fistulography with iodinated contrast.
- Collected estimated glomerular filtration rate (eGFR) data for 6 months pre- and post-procedure.
- Analyzed eGFR decline rates using mixed linear regression, accounting for contrast volume, fluids, and N-acetylcysteine (NAC).
Main Results:
- 27 patients underwent 44 fistulograms with a median contrast volume of 12 mL.
- No patients required acute dialysis post-procedure.
- No statistically significant difference in eGFR decline rate was observed before and after fistulography, even after adjusting for clinical variables.
Conclusions:
- Fistulography with limited iodinated contrast volumes is safe in advanced CKD.
- The procedure does not lead to accelerated progression of chronic kidney disease.
- This suggests fistulography can be performed without significantly increasing the risk of kidney function deterioration in this vulnerable population.
Background/Aims:
Contrast-induced acute kidney injury (CIAKI) is associated with an accelerated progression of underlying chronic kidney disease (CKD). We sought to characterize the rate of loss of kidney function following fistulography in patients with advanced CKD.
Materials/Methods:
We identified all patients with stage 4 or 5 non-dialysis-dependent CKD who underwent fistulography with iodinated contrast for non-maturing arteriovenous fistulae between 1 January 2010 and 30 November 2011. We recorded all eGFR values measured during the 6 months prior to and 6 months following the procedure, the volume and type of contrast, use of intravenous fluid and N-acetylcysteine (NAC), and timing of dialysis initiation following the procedure. We used mixed linear regression with random effects to compare the composite slope of decline in eGFR prior to and following fistulography.
Results:
Overall, 27 patients underwent a total of 44 fistulograms. The mean age of the patients was 66 years and mean baseline eGFR was 16.7 ± 5 mL/min/1.73 m(2). Patients received a median volume of contrast of 12 mL [IQR 10-20]. None of the patients initiated acute dialysis within weeks following the procedure. In unadjusted analyses, there was no statistically significant change in the rate of decline in eGFR following fistulography compared to pre-procedure (0.14 mL/min/month versus -0.14 mL/min/month, p = 0.11). In analyses that adjusted for procedural, demographic and clinical variables, the decline in eGFR following fistulography was not statistically different than before the procedure (0.15 mL/min/month versus -0.14 mL/min/month, p = 0.11).
Conclusions:
Fistulography with small volumes of iodinated contrast in patients with advanced CKD does not result in more rapid progression of underlying CKD.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Imaging Studies VII: Vascular Imaging
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
